WK4-80300-67165 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-18
Dose 1 — Pfizer-BioNTech
2021-12-09
Dose 2 — Pfizer-BioNTech
2021-12-11
Registered in v-safe
2021-12-11
Survey response — days 1–6 daily, dose 2, dependent
MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good

Free text: Mild axillary pain and lymph node swollen

MedDRA releases: 2024-11 · check-in free text available
2021-12-12
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-18
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-27
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-13
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-20
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-18	Pfizer-BioNTech	No
2	2021-12-09	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 2, dependent

2021-12-11

Systemic reaction (other): Mild axillary pain and lymph node swollen

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Axillary pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release